BIO
Bio-Rad Sees Gradual Recovery in Life Science Market Amid Challenging End Markets
Bio-Rad, a leading developer and manufacturer of innovative biotechnology reagents and systems, recently reported its second quarter 2026 results. The company's total revenue for the period was approximately $651 million, marking a slight decline on both an as-reported and currency-neutral basis compared to the same period last year.